https://www.marketscreener.com/quote/stock/ULTRAGENYX-PHARMACEUTICAL-15672076/news/Ultragenyx-Announces-Positive-Interim-Phase-1-2-Data-in-Patients-with-Angelman-Syndrome-After-Treatm-46434273/?utm_source=telegram&utm_medium=social&utm_campaign=share